Abstract: An object of the present invention is to provide a control material which can be preferably employed in detection of 1,5-anhydro-D-glucitol and glycoalbumin, which are employed as excellent indices for diabetes. The present inventor has found that mannitol which is added to serum or plasma used as control material stabilizes 1,5-anhydro-D-glucitol and glycoalbumin present in the serum or plasma for a long period of time, and that the object can be attained through provision of (1) an agent for stabilizing control material, the agent being composed of mannitol and (2) control material containing mannitol and 1,5-anhydro-D-glucitol.

Abstract: An object of the present invention is to provide a control material which can be preferably employed in detection of 1,5-anhydro-D-glucitol and glycoalbumin, which are employed as excellent indices for diabetes. The present inventor has found that mannitol which is added to serum or plasma used as control material stabilizes 1,5-anhydro-D-glucitol and glycoalbumin present in the serum or plasma for a long period of time, and that the object can be attained through provision of (1) an agent for stabilizing control material, the agent being composed of mannitol and (2) control material containing mannitol and 1,5-anhydro-D-glucitol.

Abstract: Provided is a pulse wave propagation detection system including an electrocardiographic signal detection unit, and an eyeground image detection unit for detecting an eyeground image in synchronization with an electrocardiographic signal detected through the detection unit, which system further includes a correlation unit for correlating a change in the diameter of an eyeground vein—which diameter is measured, at the optic papilla, by use of an eyeground image synchronized with an arbitrary electrocardiographic signal—with the state of pulse wave propagation through an intracerebral blood vessel or with the state of sclerosis of a capillary artery.

Abstract: It is an object of the present invention to find out a novel gene marker by which a drug-resistant cancer cell can be detected and provide a means of efficiently and comprehensively detecting a drug-resistant cancer cell using this marker. In the present invention, gene amplifications or deletions have been analyzed in cancer cell strains resistant to drugs, which are anticancer drugs having particularly serious side effects and being administered to cancer patients at a high frequency (namely, camptothecins, cisplatins, etoposides, adriamycins (ADM), and cytosine arabinosides), and parent cancer cell strains.

Abstract: A method of detecting a virus in a specimen, whereby a Norwalk-like virus (GII) is detected by using as an index the nucleic acids of a complementary nucleotide sequence corresponding to the 4851- to 5450-positions of the nucleotide sequence of the cDNA of the prototype (standard strain) of the Norwalk-like virus (GII); and a detection kit for performing this method.

Abstract: Provided is a detection method employing a detection instrument having a plurality of wells at a surface thereof, the method including depositing a detection object, preferably in coexistence with a specific holding substance, onto the inner walls of the wells of the detection instrument; bringing a reaction solution into contact with the inner walls of the wells of the detection instrument on which the detection object has been deposited, the reaction solution containing a substance reactive with the detection object; and detecting a signal generated through this contact, to thereby evaluate the detection object. In this method, a liquid phase reaction can be efficiently performed in the detection instrument for carrying out a biological reaction (e.g., a microarray) so that samples contained in the wells are not mixed with one another, and that air bubbles are prevented from being generated in the wells.

Abstract: A method of detecting a virus in a specimen, whereby a Norwalk-like virus (GI) is detected by using as an index the nucleic acids of a complementary nucleotide sequence corresponding to the 5201- to 5700-positions of the nucleotide sequence of the cDNA of the prototype (standard strain) of the Norwalk-like virus (GI); and a detection kit for performing this method.

Abstract: Provided is a pulse wave propagation detection system including electrocardiographic signal detection means, and eyeground image detection means for detecting an eyeground image in synchronization with an electrocardiographic signal detected through the detection means, which system further includes means for correlating a change in the diameter of an eyeground vein—which diameter is measured, at the optic papilla, by use of an eyeground image synchronized with an arbitrary electrocardiographic signal—with the state of pulse wave propagation through an intracerebral blood vessel or with the state of sclerosis of a capillary artery. Provision of the pulse wave propagation detection system; i.e., means for conveniently and accurately identifying the state of blood flow in the brain or the state of sclerosis of a capillary artery, enables prevention of adverse effects of, for example, excessive drop in blood pressure.

Abstract: An arteriosclerosis detection system including an electrocardiographic signal detection device, an eyeground image detection device for detecting an eyeground image in synchronization with an electrocardiographic signal detected by the detection device. The arteriosclerosis detection system further includes an eyeground vein constriction detection device for detecting the constriction of an eyeground vein in the vicinity of a site at which the eyeground vein and an eyeground artery cross each other. The constriction is detected based on the detected eyeground image in synchronization with the electrocardiographic signal. The arteriosclerosis detection system detects the eyeground image by executing an algorithm of software, which provides an eyeground image synchronized with an electrocardiographic signal by obtaining a stationary eyeground image synchronized with an arbitrary electrocardiographic signal from an animated eyeground image.

Abstract: An object of the present invention is to provide a method of identifying a substance which acts on a newly found second human prostaglandin D2 receptor subtype that differs from the DP receptor, and is useful for treating or preventing various diseases. In order to attain the object, the present invention provides a method of identifying properties of a test substance with respect to a human prostaglandin D receptor, by establishing correlation between the effect of a test substance on human CRTH2 with the effect of the test substance on the human prostaglandin D receptor.

Abstract: Hepatitis C virus-biding protein has been found to be a 40S ribosomal protein S5 composing a 40S ribosomal subunit of an eukaryote. On the basis of this finding, there is provided a method for screening test substances for a substance exhibiting anti-hepatitis-C-virus activity, through detection of inhibitory activity of the substance against binding between an IRES of a hepatitis C virus gene and a 40S ribosomal protein S5.

Abstract: A tumor suppressor gene (TSLL1 gene) having a nucleotide sequence encoding an amino acid sequence of SEQ ID NO: 1. The gene is useful in the prevention and treatment of cancers. Proteins, vectors, transformants and antibodies related to the gene are also disclosed.

Abstract: A tumor suppressor gene (TSLL2 gene) having a nucleotide sequence encoding an amino acid sequence of SEQ ID NO: 1. The gene is useful in the prevention and treatment of cancers. Proteins, vectors, transformants, and antibodies related to the gene are also disclosed.

Abstract: The invention is drawn to detect arteriosclerosis by convenient and sensitive means. The present inventors have found that such means can be obtained by use of an arteriosclerosis detection system including electrocardiographic signal detection means, eyeground image detection means for detecting an eyeground image in synchronization with an electrocardiographic signal detected by the detection means, and eyeground vein constriction detection means for detecting the constriction of an eyeground vein in the vicinity of a site at which the eyeground vein and an eyeground artery cross each other, on the basis of the eyeground image detected in synchronization with the electrocardiographic signal.

Abstract: The present specification provides a means for specifying the condition and type of immune-related diseases on the basis of knowledge about the polarization of the distribution of helper T-cell subsets Th1 and Th2. More specifically, the gene (B19), specific only to the human Th2, is prepared by a subtraction method. A human-Th2-specific protein which the gene encodes is produced by recombinant methods, and a monoclonal antibody against the Th2-specific protein and a hybridoma which produces the monoclonal antibody is provided.

Abstract: The present invention provides for specifying the condition and type of immune-related diseases on the basis of the knowledge about the polarization of the distribution of helper T-cell subsets Th1 and Th2. More sepcifically, in this invention, the gene (B19) specific only the human Th2 is prepared and specified by a subtraction method, and a recombinant vector into which the gene is incorporated, a transformant transformed by the recombinant vector, a human-Th2-specific protein which the gene encodes and which derives from the transformant, and a monoclonal antibody against the Th2-specific protein are produced and the gene, protein, antibody, etc. are used as the means for specifying or correcting the polarization of the distribution of Th1 and Th2 to solve the above object.

Abstract: An element for specifying the condition and type of immune-related diseases on the basis of the knowledge about the polarization of distribution of Th1/Th2 subsets of helper T cells. The element for specifying or correcting the polarization of the Th1/Th2 subsets is implemented by use of a recombinant vector, a transformant, a human-Th1-specific protein, and an antibody which uses the human-Th1-specific protein as an antigen. A human-Th1-specific gene is prepared and specified by a subtraction technique and is incorporated into the recombinant vector. The transformant is formed by transforming the recombinant vector. The Th1-specific protein is encoded by the gene derived from the transformant.